{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:35:09Z","timestamp":1793435709125,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFH0076"],"award-info":[{"award-number":["2023YFH0076"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0520600"],"award-info":[{"award-number":["2024ZD0520600"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cct.2026.108464","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:29:25Z","timestamp":1788733765000},"page":"108464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of immune checkpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in locally advanced gastric cancer: study protocol of a single-center, randomised clinical trial"],"prefix":"10.1016","volume":"170","author":[{"given":"Da","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuomeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.cct.2026.108464_bb0005","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/cncr.35444","article-title":"Global cancer statistics 2022: the report offers a view on disparities in the incidence and mortality of cancer by sex and region worldwide and on the areas needing attention","volume":"130","author":"Nierengarten","year":"2024","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.cct.2026.108464_bb0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s11427-022-2218-x","article-title":"Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the us, Japan, and the Republic of Korea","volume":"66","author":"Ju","year":"2023","journal-title":"Sci. China Life Sci."},{"issue":"9","key":"10.1016\/j.cct.2026.108464_bb0015","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s12094-024-03437-0","article-title":"Current status of neoadjuvant immunotherapy for the treatment of gastric cancer","volume":"26","author":"Zhang","year":"2024","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.cct.2026.108464_bb0020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/JS9.0000000000002056","article-title":"The safety and efficacy of neoadjuvant Pd-1 inhibitor plus chemotherapy for patients with locally advanced gastric cancer: a systematic review and meta-analysis","volume":"111","author":"Yu","year":"2025","journal-title":"Int. J. Surg."},{"issue":"3","key":"10.1016\/j.cct.2026.108464_bb0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jso.27761","article-title":"Neoadjuvant chemotherapy for resectable gastric cancer is associated with better outcomes than neoadjuvant chemoradiation","volume":"130","author":"Takahashi","year":"2024","journal-title":"J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.cct.2026.108464_bb0030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","volume":"22","author":"Zhang","year":"2021","journal-title":"Lancet Oncol."},{"issue":"26","key":"10.1016\/j.cct.2026.108464_bb0035","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.20.02914","article-title":"Prodigy: a phase iii study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer","volume":"39","author":"Kang","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.cct.2026.108464_bb0040","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for Her2-negative advanced gastric cancer (Keynote-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cct.2026.108464_bb0045","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2503701","article-title":"Perioperative durvalumab in gastric and gastroesophageal junction cancer","author":"Janjigian","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cct.2026.108464_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.cct.2026.108464_bb0055","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an Fnclcc and Ffcd multicenter phase iii trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.cct.2026.108464_bb0060","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"Al-Batran","year":"2016","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.cct.2026.108464_bb0065","first-page":"1254","article-title":"The impact of preoperative underweight status on postoperative complication and survival outcome of gastric cancer patients: a systematic review and meta-analysis","volume":"70","author":"Zhao","year":"2018","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.cct.2026.108464_bb0070","doi-asserted-by":"crossref","unstructured":"Xu R, Chen XD, Ding Z. Perioperative nutrition management for gastric cancer. Nutrition (Burbank, Los Angeles County, Calif) (2022) 93:111492. Epub 2021\/10\/17. doi:https:\/\/doi.org\/10.1016\/j.nut.2021.111492.","DOI":"10.1016\/j.nut.2021.111492"},{"key":"10.1016\/j.cct.2026.108464_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clnesp.2025.02.029","article-title":"Effect of perioperative immunonutrition on outcomes in gastric cancer surgery patients: a systematic review and evidence map","volume":"67","author":"Xin","year":"2025","journal-title":"Clin. Nutrit. ESPEN"},{"issue":"12","key":"10.1016\/j.cct.2026.108464_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12122876","article-title":"Immunonutrition in operated-on gastric cancer patients: an update","volume":"12","author":"Triantafillidis","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.cct.2026.108464_bb0085","doi-asserted-by":"crossref","unstructured":"Miller LJ, Douglas C, McCullough FS, Stanworth SJ, Calder PC. Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: a systematic review of randomised controlled trials. Clin. Nutr. (2022) 41(10):2135\u201346. Epub 2022\/09\/07. doi:https:\/\/doi.org\/10.1016\/j.clnu.2022.07.039.","DOI":"10.1016\/j.clnu.2022.07.039"},{"issue":"9","key":"10.1016\/j.cct.2026.108464_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12090868","article-title":"Mixed treatments comparison of oral nutrition interventions for blood immune cell parameters in cancer patients: systematic review and network meta-analysis","volume":"12","author":"Fang","year":"2022","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.cct.2026.108464_bb0095","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.clnu.2014.12.002","article-title":"Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: a double-blind randomized clinical trial","volume":"34","author":"Talvas","year":"2015","journal-title":"Clin. Nutr."},{"issue":"7","key":"10.1016\/j.cct.2026.108464_bb0100","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/iwj.13763","article-title":"Effect of enteral Immunonutrition compared with enteral nutrition on surgical wound infection, immune and inflammatory factors, serum proteins, and cellular immunity in subjects with gastric cancer undergoing a total gastrectomy: a meta-analysis","volume":"19","author":"Fu","year":"2022","journal-title":"Int. Wound J."},{"key":"10.1016\/j.cct.2026.108464_bb0105","doi-asserted-by":"crossref","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (Checkmate 649): a randomised, open-label, phase 3 trial. Lancet (2021) 398(10294):27\u201340. Epub 2021\/06\/09. doi:https:\/\/doi.org\/10.1016\/s0140-6736(21)00797-2.","DOI":"10.1016\/S0140-6736(21)00797-2"},{"issue":"21","key":"10.1016\/j.cct.2026.108464_bb0110","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2023.19918","article-title":"Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the Orient-16 randomized clinical trial","volume":"330","author":"Xu","year":"2023","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.cct.2026.108464_bb0115","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/JS9.0000000000001119","article-title":"Efficacy and safety of neoadjuvant Sintilimab in combination with flot chemotherapy in patients with Her2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study","volume":"110","author":"Li","year":"2024","journal-title":"Int. J. Surg."},{"issue":"4_suppl","key":"10.1016\/j.cct.2026.108464_bb0120","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1200\/JCO.2023.41.4_suppl.364","article-title":"Persist: a multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (Sox) with or without Sintilimab in resectable locally advanced gastric\/gastroesophageal junction cancer (Gc\/Gejc)","volume":"41","author":"Ding","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cct.2026.108464_bb0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","article-title":"Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (Keynote-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study","volume":"25","author":"Shitara","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cct.2026.108464_bb0130","doi-asserted-by":"crossref","unstructured":"Zhou D, Zuo J, Zeng C, Zhang L, Gao X, Li G, et al. Impact of body composition, grip strength, and physical performance on clinical outcomes for locally advanced gastric cancer during neoadjuvant chemotherapy: a prospective cohort study. Nutrition (Burbank, Los Angeles County, Calif) (2024) 125:112472. Epub 2024\/05\/30. doi:https:\/\/doi.org\/10.1016\/j.nut.2024.112472.","DOI":"10.1016\/j.nut.2024.112472"},{"key":"10.1016\/j.cct.2026.108464_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1061044","article-title":"Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cct.2026.108464_bb0140","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ejso.2020.04.008","article-title":"A systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection","volume":"46","author":"Deftereos","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.cct.2026.108464_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12957-024-03348-y","article-title":"Effect of preoperative immunonutrition on postoperative short-term clinical outcomes in patients with gastric cancer cachexia: a prospective randomized controlled trial","volume":"22","author":"Yu","year":"2024","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.cct.2026.108464_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12967-018-1448-0","article-title":"The influence of diet on anti-cancer immune responsiveness","volume":"16","author":"Soldati","year":"2018","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.cct.2026.108464_bb0155","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/gutjnl-2017-315537","article-title":"Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine","volume":"67","author":"Ogino","year":"2018","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cct.2026.108464_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009063","article-title":"Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision","volume":"12","author":"Emens","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cct.2026.108464_bb0165","article-title":"Effects of polyunsaturated fatty acids on gastric Cancer immunity and immunotherapy","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cct.2026.108464_bb0170","doi-asserted-by":"crossref","unstructured":"Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T, et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell (2016) 167(3):829\u201342.e13. Epub 2016\/10\/22. doi:https:\/\/doi.org\/10.1016\/j.cell.2016.09.031.","DOI":"10.1016\/j.cell.2016.09.031"},{"issue":"10","key":"10.1016\/j.cct.2026.108464_bb0175","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.annonc.2022.07.001","article-title":"Circulating L-arginine predicts the survival of Cancer patients treated with immune checkpoint inhibitors","volume":"33","author":"Peyraud","year":"2022","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.cct.2026.108464_bb0180","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.tcb.2023.03.003","article-title":"Regulation of nucleotide metabolism in cancers and immune disorders","volume":"33","author":"Ali","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.cct.2026.108464_bb0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-022-01263-x","article-title":"Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cct.2026.108464_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109186","article-title":"Docosahexaenoic acid reverses pd-L1-mediated immune suppression by accelerating its ubiquitin-proteasome degradation","volume":"112","author":"Zhang","year":"2023","journal-title":"J. Nutr. Biochem."},{"issue":"8","key":"10.1016\/j.cct.2026.108464_bb0195","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1021\/acsnano.2c05408","article-title":"Arginine supplementation targeting tumor-killing immune cells reconstructs the tumor microenvironment and enhances the antitumor immune response","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.cct.2026.108464_bb0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426002508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:17:01Z","timestamp":1793434621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426002508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S1551714426002508"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108464","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of immune checkpoint inhibitors combined with oral immunonutrition on neoadjuvant efficacy in locally advanced gastric cancer: study protocol of a single-center, randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108464"}}